Premium
Economics of Antibiotic Use Policies
Author(s) -
Paladino Joseph A.
Publication year - 2004
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.24.18.232s.52234
Subject(s) - formulary , cefepime , risk analysis (engineering) , antimicrobial stewardship , intensive care medicine , antibiotics , multidisciplinary approach , stewardship (theology) , business , medicine , operations management , economics , antibiotic resistance , nursing , imipenem , social science , sociology , microbiology and biotechnology , politics , political science , law , biology
Today more than ever, hospitals must effectively manage the use of antibiotics to control costs and preserve their usefulness. To achieve this goal, antibiotic management must evolve from overly simplistic antibiotic cost containment to more complex, multidisciplinary, appropriate use programs that are founded on clinical outcomes‐based pharmacoeconomic analyses. This article addresses common cost‐containment activities as they relate to antibiotics and examines their consequences. Examples of successful antimicrobial stewardship and the role of pharmacoeconomic analyses also are provided. Cost‐effectiveness studies of cefepime are presented to illustrate the utility of these analyses and provide information that can form the basis for decisions regarding placement of cefepime on hospital formularies.